Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer

Effects of tegoprazan, a novel potassium-competitive acid blocker, on rat models of gastric acid-related disease

(2019) Dongkyu Kim et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia

(2019) Hiroyuki Komori et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis

(2019) Kwang Jae Lee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ-12420), a novel potassium-competitive acid blocker, in healthy male subjects

(2019) Sungpil Han et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The efficacy of vonoprazan for management of post‐endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta‐analysis

(2019) Chao Liu et al.   Journal of Digestive Diseases

Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block

(2019) Carmelo Scarpignato et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases

(2018) Tadayuki Oshima et al.   Journal of Neurogastroenterology and Motility

Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker

(2018) Hideki Mori et al.   Journal of Neurogastroenterology and Motility

25 Years of Proton Pump Inhibitors: A Comprehensive Review

(2017) Daniel S. Strand et al.   Gut and Liver

Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility

(2017) Nobuyuki Takahashi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials

(2016) H. Miwa et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

(2015) K. Ashida et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations

(2015) Hirotoshi Echizen   CLINICAL PHARMACOKINETICS

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

(2013) Jai Moo Shin et al.   Journal of Neurogastroenterology and Motility

A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands

(2011) Jun Matsukawa et al.   BIOCHEMICAL PHARMACOLOGY

Review article: sleep-related gastro-oesophageal reflux as a distinct clinical entity

(2009) W. C. ORR   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Systematic Review of the Definitions, Prevalence, and Response to Treatment of Nocturnal Gastroesophageal Reflux Disease

(2008) Lauren B. Gerson et al.   Clinical Gastroenterology and Hepatology

Control of Gastric Acid Secretion in Health and Disease

(2008) Mitchell L. Schubert et al.   GASTROENTEROLOGY